First direct comparison of MDMA and MDA reveals distinct psychedelic differences

MDMA and MDA are directly compared in a randomized, double-blind, placebo-controlled crossover trial in healthy volunteers to map their acute subjective and physical effects. Across 5 separate 13-hour sessions, the study reports that MDA lasts longer and feels more intense than MDMA, with stronger stimulant effects, more visual distortions, and more fear or “bad” drug experiences. After dosing, MDA effects persist for more than 6 hours on average versus about 4 hours for MDMA, while both peak at roughly the same 2-hour mark. The trial also finds both drugs raise comparable physiological measures, including body temperature, heart rate, pupil size, and blood pressure, and both increase oxytocin and its carrier protein neurophysin I, with MDA showing slightly stronger effects. A lysine-linked prodrug version of MDA delays onset and shifts peak timing while preserving physiological responses, while a lysine-linked MDMA prodrug shows no psychoactive or physical effects, likely due to metabolism failure. The authors conclude that standard MDMA may have a more favorable psychological profile for therapeutic use, given MDA’s longer duration and higher adverse-experience burden.